News Alert

HELP Committee Questions RFK Jr. on Drug Pricing, Medicare and Medicaid but Not 340B 

HHS Secretary nominee Robert F. Kennedy Jr. appeared before the the Senate Health, Education, Labor and Pensions Committee on Thursday.
Robert F. Kennedy Jr., President Donald Trump’s pick to lead the U.S. Department of Health and Human Services (HHS), fielded [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

‘Deceit and Lies’: State Providers Slam Dark Money Ad Targeting 340B Contract Pharmacy Access Bills

Provider groups slammed a new anti-340B ad from Building America's Future, a conservative nonprofit that does not disclose its donors.
State provider groups are forcefully pushing back against a new dark money ad campaign they say is spreading “shameful” misinformation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Georgia is 11th State to Introduce 340B Contract Pharmacy Access Bill in 2025

Georgia state Rep. Todd Jones (R) introduced a bill prohibiting drugmaker 340B contract pharmacy restrictions in the state.
Georgia has become the 11th state to introduce a 340B contract pharmacy bill in the opening weeks of the 2025 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RFK Jr. Backs PBM, Drug Pricing Reform at Senate Confirmation Hearing, 340B Not Discussed but Could Come Up Today

HHS Secretary nominee Robert F. Kennedy Jr. offered support for pharmacy benefit manager and prescription drug pricing reform, but did not comment specifically on the 340B program during his Senate Finance Committee confirmation hearing on Wednesday.
Robert F. Kennedy Jr., President Donald Trump’s (R) Health and Human Services (HHS) secretary nominee, offered support for pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump Administration Signals Support for IRA Drug Price Negotiations

The Centers for Medicare and Medicaid Services signaled in a Wednesday statement that it will continue the Inflation Reduction Act’s Medicare Part D drug price negotiations.
The Trump Administration indicated Wednesday that it will continue the Inflation Reduction Act’s (IRA) Medicare drug price negotiations, a signature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

White House Rescinds Funding Freeze, But Concern Among Health Centers Remain 

President Donald Trump (R) addressed the media Wednesday after rescinding a memo to freeze trillions of dollars of federal funds.
The White House this week issued and then quickly rescinded a policy that froze trillions in federal funding following multiple [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Anti-340B Ads Return: Dark Money Group Targets GOP-Led States Considering Contract Pharmacy Access Bills

Building America's Future released a new anti-340B ad targeted at states considering 340B legislation.
A dark money group with ties to the Trump administration has launched a new deceptive ad campaign in four states [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GOP Eyes 340B Commercial Pay Rate Cut, Advocates Slam Reconciliation Proposal

The House's budget options “menu" includes a proposal to prohibit 340B covered entities from charging employer-sponsored commercial insurance plans full price for 340B discounted drugs.
Congressional Republicans are considering a contentious proposal that would prohibit 340B covered entities from charging employer-sponsored commercial insurance plans full [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

5 Questions to Assess the Effectiveness of Your 340B Pharmacy Program and Position it for Growth

SPONSORED CONTENT

Successful

Read More »

PhRMA-backed Conservative Think Tank Suggests DOGE Should Prioritize 340B Reform to Cut Government Costs

ALEC, a drug industry-funded conservative policy group, suggested 340B reform “is a great place to start” in improving government efficiency.
A drug industry-funded conservative policy group suggested that 340B reform “should be a priority” for large scale government cost-cutting efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live